PCYC

Pharmacyclics, Inc. News Headlines

$115.8
*  
1.63
1.39%
Get PCYC Alerts
*Delayed - data as of Oct. 1, 2014  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Gilead Sciences, Inc. Stock's Stunning New Opportunity
9/30/2014 9:15:02 AM - Motley Fool

FDA Decision On Imbruvica Will Push Pharmacyclics Higher
9/29/2014 1:32:00 PM - Seeking Alpha

Cramer's Lightning Round - People Need H&R Block More Than Ever (9/17/14)
9/18/2014 4:53:00 AM - Seeking Alpha

Modest Weakness Remains Visible On Wall Street - U.S. Commentary
9/11/2014 12:04:00 PM - RTT News

5 Stocks Breaking Out With Big Volume
9/11/2014 9:30:00 AM - TheStreet

Stocks Remain Nearly Flat In Mid-Day Trading - U.S. Commentary
9/10/2014 12:16:00 PM - RTT News

Infinity Pharma (INFI) Shares Skyrocket on Cancer Drug Partnership - Stocks in the News
9/3/2014 6:47:20 PM - Zacks.com

Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
9/3/2014 6:57:00 AM - TheStreet

Gilead: Rising Short Interest Provides Yet Another Reason To Own The Stock
8/15/2014 2:40:00 PM - Seeking Alpha

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/13/2014 3:06:00 AM - Zacks.com

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
8/12/2014 2:06:00 PM - Investopedia

Patient Bulls Finally Get A New Entry Point, Thanks To Inflation Fears
8/4/2014 4:45:00 PM - Seeking Alpha

Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
8/1/2014 5:10:00 PM - Zacks.com

Pharmacyclics Slips To Q2 Loss
7/31/2014 7:30:00 PM - RTT News

Pharmacyclics (PCYC) Jumps: Stock Rises 15% - Tale of the Tape
7/30/2014 9:39:00 AM - Zacks.com

Stock Pickers Rule - Investment Ideas
7/30/2014 3:51:00 AM - Zacks.com

Stocks Give Back Ground On News Of EU Sanctions Against Russia - U.S. Commentary
7/29/2014 12:12:00 PM - RTT News

PCYC Makes Bullish Cross Above Critical Moving Average
7/29/2014 11:49:49 AM - BNK Invest

Pharmacyclics/Johnson & Johnson Drug Backed for EU Approval - Analyst Blog
7/28/2014 5:15:00 PM - Zacks.com

Press Release: FDA expands approved use of Imbruvica for chronic lymphocytic leukemia
7/28/2014 12:38:00 PM - Dow Jones Business News

Medivation Significantly Undervalued, With Xtandi Weeks Away From Prostate Cancer Label Expansion
7/21/2014 2:06:00 PM - Seeking Alpha

Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
7/21/2014 10:40:00 AM - Seeking Alpha

Stocks Under Pressure In Reaction To Yellen's Testimony - U.S. Commentary
7/15/2014 12:20:00 PM - RTT News

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment
7/8/2014 8:01:00 AM - Seeking Alpha

Individual Investor Portfolio Update: Diversifying For Growth
7/1/2014 1:40:00 AM - Seeking Alpha